Gantra 2.5MG Tablet (14’s) is a medication that contains Vericiguat as its active ingredient, with each tablet delivering a dosage of 2.5 mg. This drug is primarily indicated for the treatment of heart failure, particularly in patients with worsening chronic heart failure or those who have recently been hospitalized for heart failure exacerbations. Vericiguat works by enhancing the sensitivity of soluble guanylate cyclase, a receptor that plays a crucial role in the nitric oxide signaling pathway, leading to vasodilation and improved blood flow. The formulation of Gantra is designed to provide effective management of heart failure symptoms, ultimately improving the quality of life for patients. It is essential for patients to follow their healthcare provider’s instructions regarding the use of this medication to achieve optimal therapeutic outcomes.